Home Page   -   ditorial Board   -   Instructions to autors   -   Archive   -   Contact   -   Journal's Indexing UA   EN

Last issue

1 (94), 2020


Edition of the journal is supported partially by the grant of the Fogarty International Center (FIC) of the National Institute of Health and Illinois University, Chicago.


ISSN 2077-7477 (Print)
ISSN 2077-7485 (Online)

A journal "Dovkillia ta zdorovia" (Environment & Health) publishes the articles on the problems in the field of medical ecology, hygiene, health protection and ecological safety.

Founder of the Journal:
State Institution "O.M. Marzeiev Institute for Hygiene and Medical Ecology of the National Academy of Medical Sciences of Ukraine"

Frequency of publication:

Environment & HealthISSN: 2077-7477 eISSN: 2077-7485
No: 1 (94)   -   2020   -   Pages: 39
Sensitivity to synthetic aromacyclic amino spirits of candida isolated in the patients with type i diabetes
Osypchuk N.O.1, Nastenko V.B.1, Shyrobokov V.P.1, Korotkyi Yu.V.2
1 Department of Microbiology, Virology and Immunology, O.O. Bohomolets National Medical University, Kyiv
2 Institute of Organic Chemistry, NASU, Kyiv

: 582.282.23:57.017.4:541.4:616.37-008.64

The derivatives of aromatic amino spirits are a promising group of the substances with antimycotic effect.

Objective: The aim of the study was to investigate the sensitivity of clinical isolates of yeast-like fungi of Candida genus, obtained from oral subbiotopes of the patients with type I diabetes, to synthetic aromacyclic amino spirits and commercial antimycotics.

Materials and methods: We applied the bibliosemantic, microscopic, mycological, statistical and analytical methods in the study.

Results and discussion: 90 isolates of the representatives of Candida genus were isolated. The frequency of the isolation of yeast fungi in the oral biotope made up 66.1%. The level of oral candidiasis among patients with type I diabetes was 5.1%. C.albicans, C. glabrata, C. krusei, C. tropicalis, . kefyr were indicated in the subbiotopes of oral cavity among the representatives of Candida genus, C. Albicans takes 67.8% , C. Glabrata - 10.0% , 16 , C. Krusei - 7% -, C. Tropicalis 3.3%, S. kefyr - 2,2%. Among the compounds, Kc22 had the highest activity, which, at the concentration of 0.24-0.97 g / ml, inhibited 59.0% of the strains. Amphotericin B showed the highest activity among commercial antimycotics. Fluconazole and intraconazole were ineffective against clinical strains.

Conclusions: The frequency of the isolation of yeast fungi in the oral biotope in the patients with type I diabetes made up 66.2%. C. albicans is a predominant candid in all studied oral subbiotopes (67.8%). Clinical isolates are resistant to itraconazole (100%) and fluconazole (81.7%). All isolates were sensitive to amphotericin B (75.3%). Alkyl (aryloxyethoxy) dialkyl-aminopropanol derivatives had high anticandidous activity against all types of clinical isolates.

candidiasis, Candida, amino spirits, itraconazole, fluconazole, amphotericin B
1. Rodrigues C., Rodrigues M. and Henriques M. Candida sp. Journal of Clinical Medicine. 2019 ; 8 (1) : 76. DOI : https://doi.org/10.3390/jcm8010076
2. Karaa A. and Goldstein A. Pediatric Diabetes. 2015 ; 16 (1) ; 19. DOI : https://doi.org/10.1111/pedi.12223
3. King H., Aubert R. and Herman W. Diabetes Care. 1998 ; 21 (9) : 14141431. DOI : https://doi.org/10.2337/diacare.21.9.1414
4. Agarwal S., Raman R., Paul P., Rani P., Uthra S., Gayathree R., McCarty C. et al. Ophthalmic Epidemiology. 2005 ; 12 (2) : 143153. DOI : https://doi.org/10.1080/09286580590932734
5. Guimarães T., Nucci M., Mendonça J., Martinez R., Brito L., Silva N., Moretti M. et al. International Journal of Infectious Diseases. 2012 ; 16 (6) : 442447. DOI : https://doi.org/10.1016/j.ijid.2012.02.005
6. Khosravi A., Yarahmadi S., Baiat M., Shokri H. and Pourkabireh M. Journal de Mycologie Médicale. 2008 ; 18 (2) : 8388. doi: https://doi.org/10.1016/j.mycmed.2008.04.002
7. Tang H., Liu W., Lin H. and Lai C. Geriatrics Gerontologie International. 2015 ; 15 (6) : 688693. DOI : https://doi.org/10.1111/ggi.12329
8. Belazi M., Velegraki A., Fleva A., Gidarakou I., Papanaum L., Baka D. et al. Mycoses. 2005 ; 48 (3) : 192196. DOI : https://doi.org/10.1111/j.1439-0507.2005.01124.x
9. Gonçalves R., Miranda E., Zaia J. and Giannini M. Mycopathologia. 2006 ; 162 (2) : 8389. DOI : https://doi.org/10.1007/s11046-006-0038-5
10. Levytskyi A.P., Nikolyshyn A.K, Stupak O.P. and Stupak P.P. Ukrainskyi stomatolohichnyi almanakh. 2010 ; 2 (2) : 22-26 (in Ukrainian).
11. Wiederhold N., Tam V., Chi J., Prince R., Kontoyiannis D. and Lewis R. Antimicrobial Agents and Chemotherapie. 2006 ; 50 (2) : 469-473. DOI : https://doi.org/10.1128/AAC.50.2.469-473.2006
12. Berkow E. and Lockhart S. Infection and Drug Resistance. 2017 ; 10 : https://doi.org/237245. DOI : https://doi.org/10.2147/IDR.S118892
13. Kondoh O., Inagaki Y., Fukuda H., Mizuguchi E., Ohya Y., Arisawa M., Shimma N. et al. Biological and Pharmaceutical Bulletin. 2005 ; 8 (11) ; 2138-2141. DOI : https://doi.org/10.1248/bpb.28.2138
14. Arendrup M., Cuenca-Estrella M., Lass-Florl C. and Hope W. Clinical Microbiologie and Infection. 2012 ; 18 (7) : 246-247. DOI : https://doi.org/10.1111/j.1469-0691.2012.03880.x
Designed by: IPH NAMSU Environment & Health, 2006-2020. All rights reserved.
Use of text and graphic materials of the site is allowed only upon written permission of the editoral board.